selinexor,imatinib
karyopharm therapeutics,novartis
['#gi', 'seligist', 'imatinib', 'sarcoma']
selexinor +/- imatinib for #gist #seligist #esmo22 enhancing response to kit inhibitors promising activity in pre-treated patients good signals. exciting science. worth exploring #sarcoma 
Medical Oncology Fellow @COBLH Sarcoma Unit | Sarcoma proteomics PhD ProCan @CMRI_AUS |@myESMO YOC | AYA | Rare cancers | MedEd | ????????